Historique
Rapport
Drugs of abuse. A DEA resource guide - 2022 edition
Auteur(s) :
Drug Enforcement Administration (DEA)
Année
2022
Page(s) :
115 p.
Sous-type de document :
Guide pratique / Manual
Langue(s) :
Anglais
Éditeur(s) :
Washington : U.S. Department of Justice
Domaine :
Autres substances / Other substances ; Drogues illicites / Illicit drugs
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Thésaurus mots-clés
PRODUIT ILLICITE
;
LEGISLATION
;
MEDICAMENTS
;
CLASSIFICATION
;
CONTROLE DES STUPEFIANTS
;
DROGUES DE SYNTHESE
;
STIMULANTS
;
OPIOIDES
;
PSYCHOTROPES
;
HALLUCINOGENES
;
CANNABIS
;
FENTANYL
;
PHENOMENE EMERGENT
;
REGLEMENTATION
Thésaurus géographique
ETATS-UNIS
Note de contenu :
CONTENTS:
I. Controlled Substances Act
II. U.S. Chemical Control
III. Introduction to Drug Classes:
Narcotics
Stimulants
Depressants
Hallucinogens
Steroids
Marijuana/Cannabis
Inhalants
Designer Drugs
Drugs of Concern
I. Controlled Substances Act
II. U.S. Chemical Control
III. Introduction to Drug Classes:
Narcotics
Stimulants
Depressants
Hallucinogens
Steroids
Marijuana/Cannabis
Inhalants
Designer Drugs
Drugs of Concern
Résumé :
The U.S. Drug Enforcement Administration has released the 2022 edition of Drugs of Abuse, A DEA Resource Guide, which is designed to be a reliable resource on the most commonly used and misused drugs in the United States. Released on a periodic basis, Drugs of Abuse provides important science-based information about the harms and consequences of drug use, describing a drug’s effects on the body and mind, overdose potential, origin, legal status, and other key factors. The 2022 digital edition updates the 2020 Drugs of Abuse publication with the most current information on new and emerging trends in drug misuse and abuse, including fentanyl, marijuana and marijuana concentrates, vaping, stimulant drugs, and fake pills.
Affiliation :
USA
Titre précédent :